Samsung Biologics quarterly sales hit W1tr for first time
Samsung Biologics said Wednesday it exceeded 1 trillion won ($741 million) in quarterly sales for the first time, following the operation of its fourth plant and profits generated by long-term contract manufacturing orders.
According to regulatory filings for the July-September period, Samsung Biologics’ quarterly sales on a consolidated basis hit a record high of 1.34 trillion won, marking 18 percent on-year growth.
Operating profits were 318 billion won during the same period, down 2 percent from a year prior.
Cumulative sales and operating profits were 2.6 trillion won and 763 trillion won as of the third quarter this year, up 29 percent and 14 percent from the same period last year, respectively.
The company said its increased production capacity has been driving up its sales overall. The fourth plant with a production capacity of 240,000 liters went into full operation in June.
New contract manufacturing orders also contributed to upbeat earnings. As of October, its cumulative orders secured amounts to $11.8 billion.
Samsung Bioepis, a biosimilar developer wholly owned by Samsung Biologics, meanwhile, saw a drop in its financial showings. It recorded 262 billion won in sales and 49.2 billion won in operating profits, down 3 percent and 37 percent on-year, respectively.
“To respond quickly to the growing demand for biopharmaceuticals, Samsung Biologics is currently building its fifth plant with the goal of completing it by April 2025,” said an official from Samsung Biologics.
The fifth plant, upon completion, will have an annual production capacity of 180,000 liters.
(责任编辑:커뮤니티)
- ·[New in Korean] 'The path to happiness is forgiveness,' says Korea's first million
- ·Bedbug reports cause jitters across S. Korea
- ·NTOK Live+ to screen latest plays from UK, Netherlands
- ·From artisan to 'foreign laborer:' a French craftsman's take on Korea's construction scene
- ·Unification ministry plans to hold talks with UN Command to resume Panmunjom tour
- ·[From the Scene] Samsung bets big on package substrates for future chips
- ·Hana Bank to offer W100b in support for small business owners
- ·5 S. Koreans from Gaza arrived in Egypt via Rafah border: ministry
- ·S. Korea may decide to increase medical student quota as early as next week
- ·[Today’s K
- ·[Today’s K
- ·추미애 "尹대통령 지지율 30%대 받쳐주는 철벽통들이 있다"
- ·Political parties call for revision of military exemptions for athletes
- ·[Photo News] INDIAN CINEMA
- ·60조 역대급 세수 펑크에도…여야, 국회 운영비 364억 증액 합의
- ·OpenAI CEO's ouster was over "breakdown of communications," not "malfeasance"
- ·S Korea, UAE to hold aviation talks over potential increase in bilateral flights
- ·Will Suneung without ‘killer questions’ reduce reliance on private education?
- ·New US special envoy for N. Korean human rights issues takes office, plans to visit Seoul next week
- ·Alternative nicotine products lead to reduction in smoking rates: report
- ·Fifty Fifty's Keena marks group's 1st anniversary with apology
- ·N. Korea notifies Japan of plan to launch satellite between Wednesday and Dec. 1: report
- ·UAE President's Seoul visit postponed amid Middle East tensions
- ·Culture Ministry offers Suneung takers free exhibitions, discounted performances
- ·Prosecutors seek 5
- ·[New in Korean] Kim Hye
- ·“가자주민 삶 최악…한국지원 절실”
- ·초유의 행정전산망 '먹통'에…野 "한심하다는 말도 아깝다"